These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An information service on teratogenic agents in Brazil. Clavijo HA; Schüler L; Sanseverino MT; Giugliani R World Health Forum; 1992; 13(2-3):196. PubMed ID: 1418336 [No Abstract] [Full Text] [Related]
4. [Possible teratogenic effects of some drugs]. Caratzali A; Roman IC Morphol Embryol (Bucur); 1975; 21(2):129-33. PubMed ID: 129681 [No Abstract] [Full Text] [Related]
5. Potential subversion of pregnancy prevention program in the managed care setting. Wilkin JK Arch Dermatol; 1997 Feb; 133(2):243-4. PubMed ID: 9041846 [No Abstract] [Full Text] [Related]
7. Prescription of teratogenic medications in United States ambulatory practices. Schwarz EB; Maselli J; Norton M; Gonzales R Am J Med; 2005 Nov; 118(11):1240-9. PubMed ID: 16271908 [TBL] [Abstract][Full Text] [Related]
8. The way women perceive teratogenic risk. Koren G Can J Clin Pharmacol; 2007; 14(1):e10-6. PubMed ID: 17213504 [No Abstract] [Full Text] [Related]
9. Preventive effect of riboflavin and ATP on the teratogenic effects of the phenothiazine derivative T-82. Horvath C; Szonyi L; Mold K Teratology; 1976 Oct; 14(2):167-70. PubMed ID: 982312 [TBL] [Abstract][Full Text] [Related]
10. Informing patients of the teratogenic potential of mood stabilizing drugs: a case note review of the practice of psychiatrists. James L; Barnes TR; Lelliott P; Taylor D; Paton C J Psychopharmacol; 2007 Nov; 21(8):815-9. PubMed ID: 17881432 [TBL] [Abstract][Full Text] [Related]
11. [Information services on teratogens and agents toxic for the reproduction]. Garbis-Berkvens JM; Peters PW Ned Tijdschr Geneeskd; 1991 Mar; 135(9):384-7. PubMed ID: 2014060 [No Abstract] [Full Text] [Related]
12. Present status of drugs as teratogens in man. Wilson JG Teratology; 1973 Feb; 7(1):3-15. PubMed ID: 4571463 [No Abstract] [Full Text] [Related]
13. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200 [TBL] [Abstract][Full Text] [Related]
17. Human teratogens and evidence-based teratogen risk counseling: the Motherisk approach. Nava-Ocampo AA; Koren G Clin Obstet Gynecol; 2007 Mar; 50(1):123-31. PubMed ID: 17304029 [TBL] [Abstract][Full Text] [Related]
18. The Antiretroviral Pregnancy Registry Interim Report. Preboth M Am Fam Physician; 2000 Apr; 61(7):2265. PubMed ID: 10779261 [No Abstract] [Full Text] [Related]
19. [The role of teratology in medical practice]. Peterka M; Jelínek R; Fára M; Cerný M Cesk Pediatr; 1985 Nov; 40(11):657-60. PubMed ID: 4085009 [No Abstract] [Full Text] [Related]
20. Counseling adolescents about environmental teratogens. Williams JK Pediatr Nurs; 1986; 12(4):292-5, 304. PubMed ID: 3637772 [No Abstract] [Full Text] [Related] [Next] [New Search]